Yale University
Yale Center for Clinical Investigation
The YCCI has been to establish a home for the training of the next generation of clinical and translational scientists and to provide a robust infrastructure that promotes innovative and collaborative research directed at improving patient care. Our key goals are to:
Attract talented students and junior faculty members from the Schools of Medicine, Nursing, Public Health, and Engineering into clinical and translational research careers; imbue them with a spirit of discovery; train them in the use of state-of-the-art research tools; and give them the skills needed to function collaboratively as members of multidisciplinary research teams.
Accelerate the movement of disease-related discoveries into the clinic by providing research teams with pilot grants, access to state-of-the-art research cores, and robust administrative, regulatory, informatics, biostatistics, and subject recruitment support for T1-T4 research.
Strengthen the infrastructure that connects clinical research teams with practitioners, community health clinics, and community stakeholders throughout Connecticut, reaching out in particular to diverse populations including children, women, the elderly, and underserved minorities.
Work actively with other CTSA hubs to share research approaches, expertise, tools, data, and the integration of informatics systems and other key research functions.- Yale University
Bidirectional Partnerships: Moving at the Speed of Trust to Speed Innovation: Yale School of Medicine (YSM) and its Yale Center for Clinical Investigation (YCCI), the administrative home of the Yale CTSA, has had great success advancing health and research equity through the science of translation and collaboration, including: Addressing community health equity and capacity building with the
-CLICPlease join us for the William Schnaper TL1 Visiting Scientist Grand Rounds on March 7, 2022 at 10:00am ET. Tara Bautista, PhD, Yale School of Medicine, will present at UC Davis on: Parenting Mindfully for Health: Examining Stress and Coping Among Parents of Young Children
-
-Yale University
Please join us for the TL1 Visiting Scientist Grand Rounds on February 25, 2022 from 12:00pm-1:00pm ET Vanessa Hull, BS, BA, MS, PhD Candidate at UC Davis will be presenting: Targeting N-acetyl-L-aspartate synthesis and transport to treat Canavan leukodystrophy
-Yale UniversityThe CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
- Yale University
Yale School of Medicine (YSM) and its Yale Center for Clinical Investigation (YCCI) has had great success addressing the issue of minority participation in clinical trials. Two elements that are key to the successes at Yale are electronic health record strategies and community engagement, through the Cultural Ambassador program (partnership between Yale, the African Methodist Episcopal Zion Church
Myasthenia gravis (MG) is an autoimmune disease that blocks the signal from nerve to muscle, producing weakness. The nature of the disease can range from isolated severe vision problems, like drooping eyelids or double vision, to profound general weakness leading to breathing muscle failure. Although the cause of MG is not known, the disease appears to vary based on several factors, including the
The Brain Vascular Malformation Consortium (BVMC) focuses on three rare brain conditions: familial cerebral cavernous malformation (CCM), Sturge-Weber syndrome (SWS), and hereditary hemorrhagic telangiectasia (HHT). These disorders are poorly understood, costly to manage, and can cause serious complications such as hemorrhages, seizures, and problems with spinal cord, nerve or brain function. Over
Yale UniversityWe sought to understand how U.S. residents responded to COVID-19 as it emerged, and the extent to which socioeconomic status impacted response. We found that highly resourced areas (low ADI) were concerned with stocks, social distancing, and national-level policies, while high ADI areas shared content with negative expression, prayers, and discussion of the CARES Act economic relief package
The National Institutes of Health (NIH) awarded a research team at George Washington (GW), Yale, and Duke Universities $7.8 million to establish a rare disease network for Myasthenia Gravis.
The New York and Connecticut Consortium encourages joint ventures among the New York and Connecticut area CTSA institutions (NYCON) to develop collaboration between CTSA programs in the areas of medical scientist training; the creation of regional databases of facilities; regional training opportunities for investigators and research coordinators; the exploration of barriers to improved social
Yale UniversityIn this course you will engage in a series of challenges designed to increase your own happiness and build more productive habits. As preparation for these tasks, Professor Laurie Santos reveals misconceptions about happiness, annoying features of the mind that lead us to think the way we do, and the research that can help us change. You will ultimately be prepared to successfully incorporate a
-
The New England RSA Group (NE RSA) is committed to increasing community awareness of clinical research and building clinical research capacity and sustainability in New England and beyond. Composed of representatives from the New England region's CTSA hubs, the NE RSA explores common issues, interests and concerns related to research participant safety and the experience of participation. In
-
Founded on mutual interest rather than geographic proximity, the Sharing Partnership for Innovative Research in Translation (SPIRiT) Consortium links six CTSAs together to jointly develop innovative resources to support effective translational research. Consortium goals include promoting a sharing infrastructure for research data, tools, resources, and bio-specimens; establishing a network of